Alpaslan Özgün

868 total citations
27 papers, 372 citations indexed

About

Alpaslan Özgün is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Alpaslan Özgün has authored 27 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Alpaslan Özgün's work include Cancer Immunotherapy and Biomarkers (5 papers), Testicular diseases and treatments (4 papers) and Immunotherapy and Immune Responses (4 papers). Alpaslan Özgün is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Testicular diseases and treatments (4 papers) and Immunotherapy and Immune Responses (4 papers). Alpaslan Özgün collaborates with scholars based in Türkiye, United States and Serbia. Alpaslan Özgün's co-authors include Bülent Karagöz, Oğuz Bilgi, Zeynep Eroglu, Serkan Çelik, Douglas B. Johnson, Jennifer L. McQuade, Ciara M. Kelly, Meredith McKean, Michael A. Davies and Kathryn E. Beckermann and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Immunology Research.

In The Last Decade

Alpaslan Özgün

24 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alpaslan Özgün Türkiye 10 214 116 73 66 56 27 372
Mojgan Devouassoux France 10 133 0.6× 39 0.3× 89 1.2× 99 1.5× 35 0.6× 20 480
Carmelo Bengala Italy 9 176 0.8× 41 0.4× 55 0.8× 63 1.0× 54 1.0× 19 320
Tiina M. Järvinen Finland 10 88 0.4× 158 1.4× 83 1.1× 31 0.5× 30 0.5× 14 389
Zijun Zhen China 12 155 0.7× 74 0.6× 103 1.4× 44 0.7× 60 1.1× 62 389
Lokanatha Dasappa India 9 106 0.5× 47 0.4× 36 0.5× 31 0.5× 40 0.7× 41 257
D. Tibaudi Italy 5 235 1.1× 148 1.3× 116 1.6× 30 0.5× 46 0.8× 7 424
Rahul Hejmadi United Kingdom 12 136 0.6× 91 0.8× 78 1.1× 52 0.8× 59 1.1× 34 384
G. S. Nowakowski United States 6 203 0.9× 89 0.8× 62 0.8× 19 0.3× 100 1.8× 9 429
Leting Zheng China 9 108 0.5× 142 1.2× 98 1.3× 54 0.8× 40 0.7× 18 317
Toshinari Muramatsu Japan 11 97 0.5× 44 0.4× 100 1.4× 73 1.1× 46 0.8× 42 363

Countries citing papers authored by Alpaslan Özgün

Since Specialization
Citations

This map shows the geographic impact of Alpaslan Özgün's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alpaslan Özgün with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alpaslan Özgün more than expected).

Fields of papers citing papers by Alpaslan Özgün

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alpaslan Özgün. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alpaslan Özgün. The network helps show where Alpaslan Özgün may publish in the future.

Co-authorship network of co-authors of Alpaslan Özgün

This figure shows the co-authorship network connecting the top 25 collaborators of Alpaslan Özgün. A scholar is included among the top collaborators of Alpaslan Özgün based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alpaslan Özgün. Alpaslan Özgün is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Demirci, Nebi Serkan, et al.. (2022). Decrease in estimated glomerular filtration rates in non-small cell lung cancer patients treated with crizotinib. Journal of Cancer Research and Therapeutics. 19(2). 376–381. 2 indexed citations
2.
Tavukçu, Hasan Hüseyin, et al.. (2020). The Clinical Significance of Seminoma Component in Testicular Mixed Germ Cell Tumour. Urologia Internationalis. 104(5-6). 489–496. 5 indexed citations
3.
Eroglu, Zeynep & Alpaslan Özgün. (2018). Updates and challenges on treatment with BRAF/MEK-inhibitors in melanoma. Expert Opinion on Orphan Drugs. 6(9). 545–551. 9 indexed citations
4.
Wang, Daniel, Zeynep Eroglu, Alpaslan Özgün, et al.. (2017). Clinical Features of Acquired Resistance to Anti–PD-1 Therapy in Advanced Melanoma. Cancer Immunology Research. 5(5). 357–362. 35 indexed citations
5.
Shiuan, Eileen, Kathryn E. Beckermann, Alpaslan Özgün, et al.. (2017). Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy. Journal for ImmunoTherapy of Cancer. 5(1). 8–8. 103 indexed citations
6.
Karagöz, Bülent, et al.. (2016). The inflammatory cytokine interleukin-23 is elevated in lung cancer, particularly small cell type. Współczesna Onkologia. 3(3). 215–219. 11 indexed citations
7.
Karagöz, Bülent, et al.. (2015). Long-term Survival after Lapatinib Rechallenge in Isolated Brain Metastasis of HER2-positive Breast Cancer. SHILAP Revista de lepidopterología. 11(1). 48–51. 1 indexed citations
8.
Özgün, Alpaslan, et al.. (2014). Mean Platelet Volume as a Prognostic Marker in Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Combined Chemotherapy. Asian Pacific Journal of Cancer Prevention. 15(15). 6421–6423. 44 indexed citations
9.
Karagöz, Bülent, et al.. (2014). HLA-G in Testicular Germ Cell Tumors. Oncology Research and Treatment. 37(5). 245–248. 5 indexed citations
10.
11.
Özgün, Alpaslan, et al.. (2014). Malignant melanoma and papillary thyroid carcinoma that were diagnosed concurrently and treated simultaneously: A case report. Oncology Letters. 9(1). 468–470. 7 indexed citations
12.
Özgün, Alpaslan, et al.. (2014). Basal cell adenocarcinoma of the parotid gland detected in a patient with breast cancer. BMJ Case Reports. 2014. bcr2014203791–bcr2014203791. 1 indexed citations
13.
Bilgi, Oğuz, et al.. (2014). Clinical immunology<br>CD4+CD25<sup>high</sup>, CD8+CD28– cells and thyroid autoantibodies in breast cancer patients. Central European Journal of Immunology. 39(3). 338–344. 4 indexed citations
14.
Özgün, Alpaslan, et al.. (2013). Clinicopathological Features and Survival of Young Turkish Patients with Testicular Germ Cell Tumors. Asian Pacific Journal of Cancer Prevention. 14(11). 6889–6892. 6 indexed citations
15.
Karagöz, Bülent, et al.. (2013). Immunoregulatory Function of HLA-G in Gastric Cancer. Asian Pacific Journal of Cancer Prevention. 14(12). 7681–7684. 47 indexed citations
16.
Özgün, Alpaslan, et al.. (2013). MicroRNA-21 as an Indicator of Aggressive Phenotype in Breast Cancer. Oncology Research and Treatment. 36(3). 115–118. 26 indexed citations
17.
Çetinkaya, Hakkı, et al.. (2012). Nesfatin-1 in advanced lung cancer patients with weight loss. Regulatory Peptides. 181. 1–3. 16 indexed citations
18.
Karagöz, Bülent, Oğuz Bilgi, Ahmet Alacacıoğlu, et al.. (2009). Mean platelet volume increase after tamoxifen, but not after anastrazole in adjuvant therapy of breast cancer. Medical Oncology. 27(2). 199–202. 10 indexed citations
19.
Karagöz, Bülent, et al.. (2009). Cerebrovascular Accident After Chemotherapy for Testicular Cancer. Military Medicine. 174(3). 320–321. 6 indexed citations
20.
Karagöz, Bülent, İlker Sücüllü, Özkan Sayan, et al.. (2009). Platelet indices in patients with colorectal cancer. Open Medicine. 5(3). 365–368. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mojgan Devouassoux Breakdown of academic impact, for papers by Carmelo Bengala Breakdown of academic impact, for papers by Tiina M. Järvinen Breakdown of academic impact, for papers by Zijun Zhen Breakdown of academic impact, for papers by Lokanatha Dasappa Breakdown of academic impact, for papers by D. Tibaudi Breakdown of academic impact, for papers by Rahul Hejmadi Breakdown of academic impact, for papers by G. S. Nowakowski Breakdown of academic impact, for papers by Leting Zheng Breakdown of academic impact, for papers by Toshinari Muramatsu
Rankless by CCL
2026